During the past decade, USF Health Morsani Center For Advanced Healthcare conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 12 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 9 clinical trials were completed. i.e. 90% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USF Health Morsani Center For Advanced Healthcare" #1 sponsor was "Pfizer" with 6 trials, followed by "University of South Florida" with 5 trials sponsored, "LEO Pharma" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Cytokinetics" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USF Health Morsani Center For Advanced Healthcare" #1 collaborator was "Integra LifeSciences Corporation" with 2 trials as a collaborator, "ALS Association" with 1 trials as a collaborator, "ALS Finding a Cure" with 1 trials as a collaborator, "Biogen" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "USF Health Morsani Center For Advanced Healthcare" are "Amyotrophic Lateral Sclerosis" (4 trials), "Psoriasis" (3 trials), "Actinic Keratosis" (2 trials), "Hemophilia A" (2 trials) and "Multiple Sclerosis" (2 trials). Many other conditions were trialed in "USF Health Morsani Center For Advanced Healthcare" in a lesser frequency.

Most popular intervention types in "USF Health Morsani Center For Advanced Healthcare" are "Drug" (20 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "AMX0035" (1 trials), "AboBoNT-A" (1 trials), "Apremilast" (1 trials) and "Apremilast (CC-10004)" (1 trials). Other intervention names were less common.

The vast majority of trials in "USF Health Morsani Center For Advanced Healthcare" are 23 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "USF Health Morsani Center For Advanced Healthcare". undefined are not yet recruiting, 5 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in USF Health Morsani Center For Advanced Healthcare, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in USF Health Morsani Center For Advanced Healthcare, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 3 trials that are defined as “Not Applicable".